Of these, AR positivity (HR: 0.27; 95% confidence interval (CI): 0.11-0.67) as well as multiple tumor (HR: 3.12; 95%CI: 1.22-7.95) was found to be an independent prognosticator of BC recurrence. This evidence concerns the gene AR and breast cancer.